Timothy Rolph - Dec 26, 2024 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Scientific Officer
Signature
/s/ Jonathan Young, Attorney-in-Fact
Stock symbol
AKRO
Transactions as of
Dec 26, 2024
Transactions value $
$0
Form type
4
Date filed
12/30/2024, 08:20 PM
Previous filing
Dec 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Gift $0 -14.1K -7.11% $0.00 184K Dec 26, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's Common Stock that the reporting person donated as a gift to a donor advised fund.